Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 26, Issue 1, 2016, Pages 20-26

  Xia, X ^a   Zhao, C ^a   Peng, F F ^a   Luo, Q M ^a   Zhou, Q ^a   Lin, Z C ^a   Yu, X Q ^a   Huang, F X ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cardiovascular mortality; Diabetes; Peritoneal dialysis; Serum uric acid

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; BIOLOGICAL MARKER; URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISORDERS OF PURINE AND PYRIMIDINE METABOLISM; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; URIC ACID BLOOD LEVEL; ADVERSE EFFECTS; AGED; BLOOD; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CHINA; COMPARATIVE STUDY; DIABETIC NEPHROPATHIES; EPIDEMIOLOGY; HYPERURICEMIA; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION;

ADULT; AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHINA; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; URIC ACID;

EID: 84952898913     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.10.011     Document Type: Article

References (30)

1. United States Renal Data System 2014 annual data report: an overview of the epidemiology of kidney disease in the United States 2014, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
2. Hill C.J., Fogarty D.G. Changing trends in end-stage renal disease due to diabetes in the United Kingdom. J Ren Care 2012, 38(Suppl. 1):S12-S22.
3. Liu Z.H. Nephrology in china. Nat Rev Nephrol 2013, 9(9):523-528.
4. Yang X., Yi C., Liu X., Guo Q., Yang R., Cao P., et al. Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract 2013, 100(3):354-361.
5. de Jager D.J., Grootendorst D.C., Jager K.J., van Dijk P.C., Tomas L.M., Ansell D., et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. J Am Med Assoc 2009, 302(16):1782-1789.
6. Zoppini G., Targher G., Negri C., Stoico V., Perrone F., Muggeo M., et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 2009, 32(9):1716-1720.
7. Xu Y., Zhu J., Gao L., Liu Y., Shen J., Shen C., et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS One 2013, 8(10):e78206.
8. Ong G., Davis W.A., Davis T.M. Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2010, 53(7):1288-1294.
9. Hsu S.P., Pai M.F., Peng Y.S., Chiang C.K., Ho T.I., Hung K.Y. Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transpl 2004, 19(2):457-462.
10. Antunovic T., Stefanovic A., Ratkovic M., Gledovic B., Gligorovic-Barhanovic N., Bozovic D., et al. High uric acid and low superoxide dismutase as possible predictors of all-cause and cardiovascular mortality in hemodialysis patients. Int Urol Nephrol 2013, 45(4):1111-1119.
11. Feng S., Jiang L., Shi Y., Shen H., Shi X., Jin D., et al. Uric acid levels and all-cause mortality in peritoneal dialysis patients. Kidney Blood Press Res 2013, 37(2-3):181-189.
12. Dong J., Han Q.F., Zhu T.Y., Ren Y.P., Chen J.H., Zhao H.P., et al. The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients. PLoS One 2014, 9(1):e82342.
13. Xia X., He F., Wu X., Peng F., Huang F., Yu X. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis. Am J Kidney Dis 2014, 64(2):257-264.
14. Latif W., Karaboyas A., Tong L., Winchester J.F., Arrington C.J., Pisoni R.L., et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol 2011, 6(10):2470-2477.
15. Lee S.M., Lee A.L., Winters T.J., Tam E., Jaleel M., Stenvinkel P., et al. Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 2009, 29(2):79-85.
16. Jeon J.S., Chung S.H., Han D.C., Noh H., Kwon S.H., Lindholm B., et al. Mortality predictive role of serum uric acid in diabetic hemodialysis patients. J Ren Nutr 2014, 24(5):336-342.
17. Skak-Nielsen H., Torp-Pedersen C., Finer N., Caterson I.D., Van Gaal L., James W.P., et al. Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One 2013, 8(3):e59121.
18. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20(7):1183-1197.
19. KDOQI: KDOQI Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007, 49(Suppl. 2):S12-S154.
20. Gehan E.A., George S.L. Estimation of human body surface area from height and weight. Cancer Chemother Rep 1970, 54(4):225-235.
21. Singh J.A. Racial and gender disparities among patients with gout. Curr Rheumatol Rep 2013, 15(2):307.
22. Ndrepepa G., Cassese S., Braun S., Fusaro M., King L., Tada T., et al. A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 2013, 23(12):1195-1201.
23. Wu C.Y., Hu H.Y., Chou Y.J., Huang N., YC Chou, Lee M.S., et al. High serum uric acid levels are associated with all-cause and cardiovascular, but not cancer, mortality in elderly adults. J Am Geriatr Soc 2015 Sep, 63(9):1829-1836.
24. Kang D.H., Park S.K., Lee I.K., Johnson R.J. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005, 16(12):3553-3562.
25. Yu M.A., Sánchez-Lozada L.G., Johnson R.J., Kang D.H. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010, 28(6):1234-1242.
26. Tang Z., Cheng L.T., Li H.Y., Wang T. Serum uric acid and endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 2009, 29(5):368-373.
27. Szwejkowski B.R., Gandy S.J., Rekhraj S., Houston J.G., Lang C.C., Morris A.D., et al. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy. J Am Coll Cardiol 2013, 62(24):2284-2293.
28. Kao M.P., Ang D.S., Gandy S.J., Nadir M.A., Houston J.G., Lang C.C., et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol 2011, 22(7):1382-1389.
29. Goicoechea M., Garcia de Vinuesa S., Verdalles U., Verde E., Macias N., Santos A., et al. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis 2015, 65(4):543-549.
30. Tsuruta Y., Nitta K., Akizawa T., Fukuhara S., Saito A., Karaboyas A., et al. Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS. Int Urol Nephrol 2014, 46(9):1833-1841.